动物狂犬病疫苗市场规模、份额和趋势分析报告:按应用(伴侣动物、家畜、野生动物)、地区、分部预测,2023-2030 年
市场调查报告书
商品编码
1178707

动物狂犬病疫苗市场规模、份额和趋势分析报告:按应用(伴侣动物、家畜、野生动物)、地区、分部预测,2023-2030 年

Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application (Companion Animals, Livestock Animals, Wildlife Animals), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

动物狂犬病疫苗市场增长和趋势

根据 Grand View Research, Inc. 的最新报告,到 2030 年,全球兽用狂犬病疫苗市场预计将达到 8.025 亿美元。从 2023 年到 2030 年,该市场预计将以 4.1% 的复合年增长率增长。推动市场的关键因素包括提高对人畜共患疾病的认识、提高流浪动物的疫苗接种率,以及政府加大力度推动到 2030 年消灭狂犬病。推动动物狂犬病疫苗接种市场的主要因素之一是对牲畜疫苗的认识和教育。有许多疫苗获批用于牲畜,包括灭活病毒载体产品、减毒病毒载体产品、IM 和 SC 注射产品、持续时间为 1-3 年的产品以及最低接种年龄的产品。定期的公共教育、负责任的宠物护理、定期的兽医治疗和疫苗接种以及持续的专业培训是狂犬病预防和控制的关键组成部分。

是预防和控制狂犬病的重要因素。通过传播有关狂犬病传播途径的知识,避免与野生动物接触和为野生动物接种狂犬病疫苗的需求将广泛传播,极大地有助于控制野生动物的感染传播。此外,疫苗接种可改善牲畜的总体状况,从而降低全因死亡率。

狂犬病是一种攻击中枢神经系统的致命性疾病,一旦出现临床症状就没有有效的治疗方法。据估计,狗的狂犬病在全球造成 860 万美元的损失,占每年发生的大约 60,000 例狂犬病死亡总数的 98%。在过去的 50 年里,美国为根除动物和人类狂犬病做出了重大努力。由于动物大规模疫苗接种方法的发展和散养规定的实施,感染狗传狂犬病的动物数量已从每年高达 10,000 例减少。儘管取得了这些进展,狂犬病仍然是一个主要的公共卫生威胁,在美国各地野生动物乔木中的浣熊、臭鼬和狐狸中流行。

在世界各地,COVID-19 大流行正在扰乱关键的卫生服务。为加速实现这一目标,联合抗狂犬病论坛于 2020 年成立,以倡导“同一个健康”战略。全球狂犬病战略的关键要素包括社区参与、改善人类狂犬病疫苗的获取以及增加对狗的大规模疫苗接种。狂犬病消除策略的进展可以用作服务不足人群获得医疗保健公平性的指标,也可以用作“同一个健康”成功的早期指标。对狗进行大规模疫苗接种是全球消除狂犬病战略的核心,目标是达到 70% 的覆盖率。大多数流行国家在分配、数量减少和进口犬疫苗方面遇到了困难。这是因为犬用疫苗最初并未列入必要项目清单。即使在讚比亚等本地製造的国家,预算限制也阻碍了犬疫苗的生产。

即使在像赞比亚这样在当地生产的国家,由于预算限制,他们也无法生产狗疫苗。

狂犬病通过唾液传播,并可通过被受感染的动物咬伤而传播。狂犬病也可以通过猴子、狗、蝙蝠甚至猫传播。印度尼西亚 98% 的狂犬病病例都是由被狂犬病犬咬伤引起的。根据 2021 年 12 月发表的国家医学图书馆论文,全球动物狂犬病病例数在过去十年中略有增加。在泰国,2017-2018 年,描述动物狂犬病的特征,使用广义相加模型评估每月狂犬病发病率与可理解因素之间的关係,并估计狂犬病流行的地理风险区域。进行了一项研究以一项调查显示,狗是泰国最常感染狂犬病的疾病。大多数被感染的狗是家养狗,自由活动,没有接种疫苗。东北地区的狂犬病感染人数最多,其次是中部地区和东北地区。

区域。短期来看,从6月开始逐渐增加,2018年1月开始明显增加。在这些狂犬病流行国家,正在采取强有力的措施,例如狗的群体免疫项目、餵养野生动物的狂犬病疫苗接种运动以及对宠物进行强制性狂犬病疫苗接种,从而促进市场的增长。预计

动物狂犬病疫苗市场报告要点

由于多个国家对宠物强制接种狂犬病疫苗、狗的大规模疫苗接种计划基本到位以及狗拥有量显着增加,伴侣动物部门将在 2022 年增长到最大值。占收入份额

由于发达地区野生动物狂犬病疫苗接种活动的增加,野生动物行业预计在预测期内以 4.4% 的最快复合年增长率增长

预计北美在预测期内将保持领先地位。这是由于该地区人均动物保健支出高和宠物拥有率高。美国几乎每个州都强制要求对宠物进行常规狂犬病疫苗接种,以期在不久的将来根除狂犬病。

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 估计/预测时间表
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查:
    • 第一次调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
  • 二级信息列表
  • 目的

第二章执行摘要

  • 2022 年市场概况(百万美元)
  • 段快照
  • 争用快照

第三章动物狂犬病疫苗市场:市场变量的趋势和范围

  • 市场系列展望
    • 母市场分析
    • 补充市场分析
  • 绘製渗透率和增长前景
  • 市场动态
    • 市场驱动力分析
    • 市场约束因素分析
    • 市场机会分析
    • 市场问题分析
  • 行业分析
    • 波特五力分析
      • 买方议价能力
      • 供应商的议价能力
      • 新进入者的威胁
      • 替代品的威胁
      • 行业竞争力:高
    • PESTEL 分析
      • 政治和法律环境
      • 经济社会形势
      • 环境状况
      • 科技景观
  • 2018 年至 2022 年按主要物种和主要国家分列的估计动物种群数量
  • 按地区和主要国家划分的东盟狂犬病病例估计数
  • 东盟地区及主要国家的狂犬病疫苗接种率(覆盖率)估计
  • 按地区分列的东盟狂犬病死亡率估计值
  • 监管框架
  • COVID-19 影响分析
    • 当前和未来的影响分析
    • COVID-19 对市场参与者的影响

第四章动物狂犬病疫苗市场:应用分析

  • 2022 年和 2030 年应用市场份额分析
  • 动物狂犬病疫苗市场:应用波动分析,2018-2030
  • 伴侣动物
    • 家畜
    • 野生动物

第五章动物狂犬病疫苗市场:区域市场应用分析,2018-2030(百万美元)

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场快照
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 波兰
    • 俄罗斯
    • 罗马尼亚
    • 土耳其
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第六章动物狂犬病疫苗市场——竞争格局

  • Merck & Co., Inc. (MSD Animal Health)
  • Indian Immunologicals Ltd.
  • Boehringer Ingelheim International GmbH (Animal Health)
  • Zoetis
  • Virbac
  • BroadChem Philippines Biopharma Corporation
  • Elanco
  • Ceva
  • BiogenesisBago
  • 参赛者概览
  • 财务绩效
  • 进入公司
    • 市场领导者
    • 战略规划
  • 私人公司名单
Product Code: GVR-4-68040-011-9

Rabies Veterinary Vaccines Market Growth & Trends:

The global rabies veterinary vaccines market size is expected to reach USD 802.5 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.1% from 2023 to 2030. The key factors driving the market include an increase in zoonotic disease awareness, boosting stray animal immunization coverage, and growing number of government initiatives with the motive of eradicating rabies by 2030. One of the main drivers propelling the market for animal rabies vaccinations is domestic animal vaccine awareness and education. There are numerous vaccines approved for use in domestic animal species, which include inactivated and modified-live virus vector products, products for IM and SC injection, products with immunization durations ranging from 1 to 3 years, and products with a range of minimum vaccination ages. Regular public education, responsible pet ownership, routine veterinary treatment and vaccinations, and continuous professional training are crucial element

s of rabies prevention and control. By spreading knowledge about rabies transmission channels, the necessity of avoiding contact with wildlife and vaccinating wildlife with bait rabies vaccines are widely initiated, which greatly helps in reducing the spread of the disease from wildlife sources. Additionally, the vaccination improves domestic animals' general health and is linked to a decline in all-cause mortality rates.

Rabies is a deadly disease that attacks the central nervous system and has no effective treatment once clinical signs appear. It is estimated that 8.6 million dollars are spent globally on canine rabies, which is responsible for 98% of approximately 60,000 total rabies deaths that occur each year. The U.S. has made enormous efforts over the past 50 years to eradicate rabies in both animal and human populations. The number of animals infected with canine-mediated rabies has decreased from up to 10,000 cases per year because of the development of mass animal vaccination procedures and the enforcement of leash restrictions. Despite these developments, rabies continues to pose a major threat to public health and is still prevalent in raccoons, skunks, and foxes in wildlife reservoirs throughout the U.S.

All around the world, the COVID-19 pandemic has disrupted crucial health services. The United Against Rabies Forum, which advocates a 'One Health' strategy, was established in 2020 to hasten the achievement of this objective. The main components of the global rabies strategy include community involvement, better access to human rabies vaccines, and expanded mass dog vaccination. The advancement of rabies eradication strategies can be used as a marker for the equity of healthcare access in underserved populations and as an early indicator for the successful implementation of 'One Health'. The core element of the global rabies elimination strategy is mass dog vaccination, with a 70% coverage rate as the goal. The majority of endemic nations saw difficulties with distribution, volume reductions, and importation delays for dog vaccines. This was because dog vaccines initially did not fit within the category of necessary items. Budget restrictions prevented the production of dog vaccines even in countries such as Zambia where they are made locally.

Rabies is spread through saliva, which means the infection can be transmitted through infected animal bites. Rabies can be transmitted by monkeys, dogs, bats, or, in some cases, cats. 98% of rabies cases in Indonesia are caused by rabid dog bites. According to an article published in December 2021, by the National Library of Medicine over the past 10 years, there has been a slight increase in the number of animal rabies cases globally. In Thailand, a study was conducted between 2017 and 2018 to identify the characteristics of animal rabies, assess the relationship between monthly rabies incidence and understandable factors using generalized additive models, and estimate the geographical risk areas for rabies spread. According to the study, dogs are the most common species in Thailand that are infected by rabies. The majority of the infected dogs were owned, roaming freely, and were not vaccinated. The northeast region of the country has the highest concentrations of rabies cases, followed by the middle and so

uthern regions. In the short term, the number of cases increased gradually after June and significantly from January in 2018. Such rabies-endemic countries are taking strong measures such as dog mass vaccination programs, wildlife bait rabies vaccination campaigns, and mandatory pet rabies vaccinations among others, which are anticipated to fuel the growth of the market.

Rabies Veterinary Vaccines Market Report Highlights:

  • The companion animals segment held the largest revenue share in 2022 owing to the mandatory pet rabies vaccinations regulated in several countries, largely conducted mass dog vaccination programs, and significantly rising dog ownership rates
  • The wildlife animals segment is anticipated to expand at the fastest CAGR of 4.4% over the forecast period owing to the rising wildlife rabies vaccination campaigns in developed regions
  • North America is expected to maintain its lead over the forecast period. This is due to the region's high per capita animal healthcare spending and a large number of pet ownership rates. Almost every state in the U.S. mandates regular rabies vaccination for pets with the mission of eradicating rabies in the near future

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List of Secondary Sources
  • 1.8 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot, 2022 (USD Million)
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Rabies Veterinary VaccinesMarket: Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.4 Industry Analysis
    • 3.4.1 Porter's 5 Forces Analysis
      • 3.4.1.1 Bargaining Power of Buyers
      • 3.4.1.2 Bargaining Power of Suppliers
      • 3.4.1.3 Threat of New Entrants
      • 3.4.1.4 Threat of Substitutes
      • 3.4.1.5 Industry Rivalry: High
    • 3.4.2 Pestel Analysis
      • 3.4.2.1 Political & Legal Landscape
      • 3.4.2.2 Economic & Social Landscape
      • 3.4.2.3 Environmental Landscape
      • 3.4.2.4 Technology Landscape
  • 3.5 Estimated Animal Population by Key Species and Key Countries, 2018-2022
  • 3.6 ASEAN Estimated Rabies Patient Volumes, by Region & Key Countries
  • 3.7 ASEAN Estimated Spread Rate (Coverage) of Rabies Vaccination, by Region & Key Countries
  • 3.8 ASEAN Estimated Rabies Mortality Rate, by Region
  • 3.9 Regulatory Framework
  • 3.10 COVID-19 Impact Analysis
    • 3.10.1 Current and Future Impact Analysis
    • 3.10.2 Impact of COVID-19 on Market Players

Chapter 4 Rabies Veterinary VaccinesMarket: Application Analysis

  • 4.1 ApplicationMarket Share Analysis, 2022 & 2030
  • 4.2 Rabies Veterinary VaccinesMarket: Application movement Analysis, 2018 to 2030
  • 4.3 Companion Animals
    • 4.3.1 Companion animalsMarket estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2 Livestock Animals
      • 4.3.2.1 Livestock animals Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.3 Wildlife Animals
      • 4.3.3.1 Wildlife animals Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Rabies Veterinary Vaccines Market: Regional Market Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1 Regional Market Share Analysis, 2022& 2030
  • 5.2 Regional Market Snapshot
  • 5.3 North America
    • 5.3.1 North America Rabies Veterinary Vaccines Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 5.3.2 U.S.
      • 5.3.2.1 U.S. Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.3 Canada
      • 5.3.3.1 Canada Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4 Europe
    • 5.4.1 Europe Rabies Veterinary Vaccines Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 5.4.2 Poland
      • 5.4.2.1 Poland Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3 Russia
      • 5.4.3.1 Russia Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4 Romania
      • 5.4.4.1 Romania Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.5 Turkey
      • 5.4.5.1 Turkey Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.6 Spain
      • 5.4.6.1 Spain Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5 Asia Pacific
    • 5.5.1 Asia Pacific Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2 Japan
      • 5.5.2.1 Japan Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3 China
      • 5.5.3.1 China Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4 India
      • 5.5.4.1 India Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5 South Korea
      • 5.5.5.1 South Korea Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6 Thailand
      • 5.5.6.1 ThailandRabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6 Latin America
    • 5.6.1 Latin America Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2 Brazil
      • 5.6.2.1 Brazil Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3 Mexico
      • 5.6.3.1 Mexico Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.4 Argentina
      • 5.6.4.1 Argentina Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7 MEA
    • 5.7.1 MEA Rabies Veterinary Vaccines Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 5.7.2 South Africa
      • 5.7.2.1 South Africa Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3 Saudi Arabia
      • 5.7.3.1 Saudi Arabia Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.4 UAE
      • 5.5.4.1 UAE Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6Rabies Veterinary VaccinesMarket - Competitive Landscape

  • 6.1 Merck & Co., Inc. (MSD Animal Health)
  • 6.2 Indian Immunologicals Ltd.
  • 6.3 Boehringer Ingelheim International GmbH (Animal Health)
  • 6.4 Zoetis
  • 6.5 Virbac
  • 6.6 BroadChem Philippines Biopharma Corporation
  • 6.7 Elanco
  • 6.8 Ceva
  • 6.9 BiogenesisBago
  • 6.10 Participant's Overview
  • 6.11 Financial Performance
  • 6.12 Participant Categorization
    • 6.12.1 Market Leaders
    • 6.12.2 Strategy Mapping
  • 6.13 List of Private Players

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of key companies
  • Table 3. North America Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America Rabies Veterinary Vaccines market, by application, 2018 - 2030 (USD Million)
  • Table 5. U.S. Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 6. Canada Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 7. Europe Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 8. Europe Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 9. Poland Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 10. Russia Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 11. Romania Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 12. Turkey Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 13. Spain Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 14. Asia pacific Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 15. Asia pacific Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 16. China Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 17. Japan Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 18. India Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 19. South Korea Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 20. Thailand Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 21. LATAM Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 22. LATAM Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 23. Brazil Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 24. Mexico Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 25. Argentina Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 26. MEA Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 27. MEA Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 28. South Africa Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 29. Saudi Arabia Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 30. UAE Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 31. Global Rabies Veterinary Vaccines market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Rabies Veterinary Vaccines Market Application outlook: Key takeaways, 2022 & 2030
  • Fig. 15 Rabies Veterinary Vaccines Market: Application movement analysis
  • Fig. 16 Global companion animals market 2018 - 2030 (USD Million)
  • Fig. 17 Global livestock animals market 2018 - 2030 (USD Million)
  • Fig. 18 Global wildlife animals market 2018 - 2030 (USD Million)
  • Fig. 19 Regional outlook, 2022 & 2030
  • Fig. 20 Regional marketplace: Key takeaways
  • Fig. 21 North America Rabies Veterinary Vaccines Market by countries, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 24 Europe Rabies Veterinary Vaccines market by countries, 2018 - 2030 (USD Million)
  • Fig. 25 Poland Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 26 Russia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 27 Romania Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 28 Turkey Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 29 Spain Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 30 Asia Pacific Rabies Veterinary Vaccines market by countries, 2018 - 2030 (USD Million)
  • Fig. 31 China Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 32 Japan Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 33 India Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 34 South Korea Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 35 Thailand Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 36 Latin America Rabies Veterinary Vaccines market by countries, 2018 - 2030 (USD Million)
  • Fig. 37 Brazil Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 39 Argentina Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 40 MEA Rabies Veterinary Vaccines market by countries, 2018 - 2030 (USD Million)
  • Fig. 41 South Africa Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 42 Saudi Arabia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 43 UAE Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 44 Market participant categorization
  • Fig. 45 Company market position analysis